AstraZeneca Stock Price, News & Analysis (LON:AZN)

GBX 6,979

+63.00 (+0.91 %)

(As of 10/14/2019 04:00 PM ET)

Add

Compare

Today's Range

6,903

Now: GBX 6,979▼

7,002

50-Day Range

6,793

MA: GBX 7,168.23▼

7,533

52-Week Range

5,312

Now: GBX 6,979▼

8,227.88

Volume1.61 million shs

Average Volume2.31 million shs

Market Capitalization£91.56 billion

P/E Ratio40.77

Dividend Yield3.17%

BetaN/A

AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Qtern, Symlin, Xigduo, and Xigduo XR for metabolic diseases. Read More…

Industry, Sector and Symbol

Stock Exchange LON

Industry Drug Manufacturers - Major

Sub-IndustryN/A

SectorMedical

Current SymbolLON:AZN

Previous Symbol

CUSIPN/A

CIKN/A

Webhttp://www.astrazeneca.com/

Phone+44-20-73045000

Debt

Debt-to-Equity Ratio144.48

Current Ratio0.95

Quick Ratio0.74

Price-To-Earnings

Trailing P/E Ratio40.77

Forward P/E Ratio18.27

P/E GrowthN/A

Sales & Book Value

Annual Sales£23.07 billion

Price / Sales3.97

Cash FlowGBX 474.46 per share

Price / Cash Flow14.71

Book ValueGBX 1,033.40 per share

Price / Book6.75

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Employees64,400

Outstanding Shares1,311,890,048

Market Cap£91.56 billion

Next Earnings Date10/24/2019 (Estimated)

OptionableOptionable

Receive AZN News and Ratings via Email

Sign-up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter.

AstraZeneca (LON:AZN) Frequently Asked Questions

What is AstraZeneca's stock symbol?

AstraZeneca trades on the London Stock Exchange (LON) under the ticker symbol "AZN."

How often does AstraZeneca pay dividends? What is the dividend yield for AstraZeneca?

AstraZeneca announced a dividend on Thursday, July 25th. Investors of record on Thursday, August 8th will be paid a dividend of GBX 71.90 per share on Monday, September 9th. This represents a dividend yield of 1.07%. The ex-dividend date is Thursday, August 8th. The official announcement can be accessed at this link. View AstraZeneca's Dividend History.

When is AstraZeneca's next earnings date?

AstraZeneca is scheduled to release their next quarterly earnings announcement on Thursday, October 24th 2019. View Earnings Estimates for AstraZeneca.

What price target have analysts set for AZN?

18 equities research analysts have issued 1 year price objectives for AstraZeneca's stock. Their predictions range from GBX 5,180 to £100. On average, they expect AstraZeneca's share price to reach GBX 7,062.50 in the next year. This suggests a possible upside of 1.2% from the stock's current price. View Analyst Price Targets for AstraZeneca.

What is the consensus analysts' recommendation for AstraZeneca?

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca in the last year. There are currently 3 sell ratings, 6 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for AstraZeneca.

Has AstraZeneca been receiving favorable news coverage?

Media stories about AZN stock have been trending negative recently, according to InfoTrie Sentiment. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. AstraZeneca earned a news impact score of -2.8 on InfoTrie's scale. They also assigned news coverage about the biopharmaceutical company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for AstraZeneca.

Who are some of AstraZeneca's key competitors?

Some companies that are related to AstraZeneca include GlaxoSmithKline (GSK), Bayer (BAYN), Dechra Pharmaceuticals (DPH), Hutchison China MediTech (HCM), Mayne Pharma Group (MYX), Opthea (OPT), Vectura Group (VEC), Medical Developments International (MVP), Eco Animal Health Group (EAH), BEXIMCO PHARMAC/S GDR REGS (BXP), Trilogy International Partners (TRL), Allergy Therapeutics (AGY), Pharmaxis (PXS), Futura Medical (FUM) and Vita Life Sciences (VLS).

What other stocks do shareholders of AstraZeneca own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AstraZeneca investors own include GlaxoSmithKline (GSK), Vodafone Group (VOD), Hain Celestial Group (HAIN), National Retail Properties (NNN), NVIDIA (NVDA), BP (BP), Marks and Spencer Group (MKS), Royal Dutch Shell (RDSB), Encana (ECA) and Philip Morris International (PM).

Who are AstraZeneca's key executives?

AstraZeneca's management team includes the folowing people:

Mr. Pascal Soriot, CEO & Exec. Director (Age 60)
Mr. Marc Dunoyer, CFO & Exec. Director (Age 67)
Ms. Pam P. Cheng, Exec. Vice-Pres of Operations & Information Technology (Age 48)
Thomas Kudsk Larsen, Head of Investor Relations
Mr. Jefrey Pott, Gen. Counsel

How do I buy shares of AstraZeneca?

Shares of AZN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is AstraZeneca's stock price today?

One share of AZN stock can currently be purchased for approximately GBX 6,979.

How big of a company is AstraZeneca?

AstraZeneca has a market capitalization of £91.56 billion and generates £23.07 billion in revenue each year. AstraZeneca employs 64,400 workers across the globe.View Additional Information About AstraZeneca.

What is AstraZeneca's official website?

The official website for AstraZeneca is http://www.astrazeneca.com/.

How can I contact AstraZeneca?

AstraZeneca's mailing address is 1 Francis Crick Avenue Cambridge Biomedical Campus, CAMBRIDGE, CB2 0AA, United Kingdom. The biopharmaceutical company can be reached via phone at +44-20-73045000.

MarketBeat Community Rating for AstraZeneca (LON AZN)

Community Ranking:		2.3 out of 5 ( )
Outperform Votes:		1,454 (Vote Outperform)
Underperform Votes:		1,645 (Vote Underperform)
Total Votes:		3,099

MarketBeat's community ratings are surveys of what our community members think about AstraZeneca and other stocks. Vote "Outperform" if you believe AZN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AZN will underperform the S&P 500 over the long term. You may vote once every thirty days.

This page was last updated on 10/14/2019 by MarketBeat.com Staff

Featured Article: Why Dividend Stocks May Be Right for You